Greenstone Bio is a commercial stage computational biology company specializing in stem cell technology, artificial intelligence & machine learning, and drug discovery. The company’s drug discovery platform is fueled by an exceptional data trove, augmented with machine learning, and grounded by stem cell biology. Greenstone Bio has established extensive knowledge and expertise in generating patient-derived human iPSCs and differentiation into numerous cell types for disease modeling and drug discovery. The company is co-founded by Dr. Joseph C. Wu, a board-certified cardiologist who is Director of the Stanford Cardiovascular Institute and Professor of Medicine and Radiology at the Stanford University School of Medicine, and by Jade Chao, a patent attorney who is well versed in human iPSC biology.Meet the company
Location: United States
Investors 2
| Date | Name | Website |
| - | Walden Cat... | waldencata... |
| 23.10.2022 | AE Investm... | aeinvestme... |
Mentions in press and media 5
| Date | Title | Description |
| 25.08.2026 | Ours Privacy Secures $15M Series A for HIPAA-Compliant Health Marketing Platform | Ours Privacy secured $15 million in Series A funding. The HIPAA-compliant Customer Data Platform (CDP) empowers healthcare marketers. It navigates strict privacy regulations. The platform enables growth while safeguarding patient data. Ligh... |
| 20.08.2026 | Greenstone Biosciences Wins Breakthrough T1D Grant To Build Patient-Derived 3D Islet Platform With Multi-Omics | Greenstone Biosciences has received a Breakthrough T1D Industry Discovery and Development Partnership grant to develop a patient-derived islet cell platform aimed at improving understanding of insulin-producing beta cells in people with typ... |
| 19.08.2026 | Ours Privacy Raises $15M in Series A Funding | Ours Privacy, a Houston, Texas-based provider of a HIPAA-compliant customer data platform (CDP) for healthcare marketers, raised $15M in Series A funding. The round was led by Lightbank and Health Velocity Capital with participation from Ro... |
| 19.08.2026 | Greenstone Biosciences Receives Breakthrough T1D Grant | Greenstone Biosciences, a Palo Alto, CA-based biotechnology company integrating AI-based drug discovery with clinical genomics and iPSC platforms, received a Breakthrough T1D grant. The amount of the deal was not disclosed. The company inte... |
| 19.08.2026 | Flip Raises $25M in New Funding | Flip, a Stuttgart, Germany-based AI-native employee experience platform for frontline workers, raised $25M in new funding. Backers included Notion Capital, HV Capital, L-Bank, and a group of angel and institutional investors. The company in... |